ORIC: Bathi resik saben saham sajrone 12 wulan pungkasan oricpharma.com

ORIC Pharmaceuticals operates as a virtual biopharma, fully outsourcing synthesis and clinical trials to external contractors. The company's rolling annual profit per share illustrates revenue dynamics, where -1.35 represents the current level of the metric. The business focuses on combating drug-resistant tumors. Development relies on venture capital and close partnerships with industry behemoths to create combination therapies.

ORIC (ORIC Pharmaceuticals) riwayat Bathi resik saben saham (EPS TTM) saka 04.07.2022 nganti 10.11.2026

Rincian analitis perusahaan ORIC Pharmaceuticals

- rega saham lan prakiraan rega para ahli:

Kutipan saham ORIC Pharmaceuticals|ORIC - Konsensus nilai wajar

- informasi kapitalisasi pasar:

Biji pasar ORIC Pharmaceuticals, Inc.|ORIC - Total Nilai Bisnis

- indikator nilai aset resik miturut neraca:

Nilai Buku saben Saham ORIC Pharmaceuticals|ORIC - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku oricpharma.com|ORIC - Nilai Agregat Aset

- rincian struktur utang lan likuiditas bisnis:

Total Utang marang Modal ORIC Pharmaceuticals|ORIC - Tanggungan utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal ORIC Pharma|ORIC - Utang kumulatif perusahaan|Utang marang nilai buku ORIC Pharmaceuticals, Inc.|ORIC - Gedhene kewajiban jangka dawa|Utang jangka cendhak perusahaan ORIC Pharmaceuticals|Rasio cepet oricpharma.com

- indikator pendapatan resik lan kelipatan nilai:

ORIC - Bathi perusahaan|Bathi mangsa ngarep ORIC Pharmaceuticals|ORIC - Nilai perusahaan marang bathi resik|Prakiraan rega marang bathi ORIC Pharmaceuticals, Inc.|ORIC - Rasio nilai perusahaan marang wutah bathi|Pangali EV/EBITDA ORIC Pharmaceuticals, Inc.|ORIC - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) ORIC Pharmaceuticals|ORIC - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan oricpharma.com|ORIC - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep ORIC Pharmaceuticals

Analisis dhasar perusahaan:ORIC Pharmaceuticals - ORIC

Produk sing diprodhuksi ORIC Pharmaceuticals Inc

To isolate the fundamental stability of ORIC Pharmaceuticals (ORIC) from market noise, net earnings per share is utilized, which distributes total income across all securities to determine the real return on each share of the business. An analysis of the rolling year earnings per share confirms the financial efficiency of investments in targeted oncology therapy and the highly qualified staff of biologists developing breakthrough treatments.

Karo sapa ORIC Pharmaceuticals saingan